Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
| Revenue (Most Recent Fiscal Year) | $2.52B |
| Net Income (Most Recent Fiscal Year) | $102.98M |
| PE Ratio (Current Year Earnings Estimate) | 18.42 |
| PE Ratio (Trailing 12 Months) | 18.92 |
| PEG Ratio (Long Term Growth Estimate) | 1.71 |
| Price to Sales Ratio (Trailing 12 Months) | 3.16 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.94 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 8.81 |
| Pre-Tax Margin (Trailing 12 Months) | 9.28% |
| Net Margin (Trailing 12 Months) | 7.39% |
| Return on Equity (Trailing 12 Months) | 10.52% |
| Return on Assets (Trailing 12 Months) | 8.56% |
| Current Ratio (Most Recent Fiscal Quarter) | 4.45 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.72 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 1.41 |
| Book Value per Share (Most Recent Fiscal Quarter) | $30.40 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.68 |
| Earnings per Share (Most Recent Fiscal Year) | $3.04 |
| Diluted Earnings per Share (Trailing 12 Months) | $1.34 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 135.38M |
| Free Float | 110.32M |
| Market Capitalization | $7.94B |
| Average Volume (Last 20 Days) | 1.03M |
| Beta (Past 60 Months) | 1.20 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 18.51% |
| Percentage Held By Institutions (Latest 13F Reports) | 95.16% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |